IP Library Granted Patent US 7,112,420
Granted Patent B2
US 7,112,420 · App. 09/957,635 · Granted Sep 26, 2006

Lymphoma associated molecules and uses therefor

Assignee: Dana-Farber Cancer Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,112,420
App. No.
09/957,635
Granted
Sep 26, 2006
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.

Claims (11)

1. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:1, or a full complement thereof.

2. An isolated nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 2, or a full complement of said nucleic acid molecule.

3. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:3, or a full complement thereof.

4. An isolated nucleic acid molecule consisting of the nucleotide sequence set forth in SEQ ID NO:1, or a full complement thereof.

5. An isolated nucleic acid molecule consisting of the nucleotide sequence set forth in SEQ ID NO:3, or a full complement thereof.

6. An isolated nucleic acid molecule which encodes a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO: 2, or a full complement of said nucleic acid molecule.

7. An isolated nucleic acid molecule comprising the nucleic acid molecule of any one of claims 1 , 2 , 3 , 4 , 5 , or 6 , and a nucleotide sequence encoding a heterologous polypeptide.

8. A vector comprising the nucleic acid molecule of any one of claims 1 , 2 , 3 , 4 , 5 , or 6 .

9. The vector of claim 8 , which is an expression vector.

10. An isolated host cell transfected with the expression vector of claim 9 .

11. A method of producing a polypeptide comprising culturing the isolated host cell of claim 10 in an appropriate culture medium to, thereby, produce the polypeptide.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 15, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040040/0998 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2002
From: SHIPP, MARGARET A.; AGUIAR, RICARDO; GU, LIQUN; TAKEYAMA, KUNIHIKO
To: DANA-FARBER CANCER INSTITUTE
Reel/Frame 012732/0677 →
Continuity (2)
Provisional Application 6023379100 · Sep 19, 2000
Related Publication 20020120112A1 · Aug 29, 2002